PAD4 has been proposed as a critical enzyme in the formation of NETs and its deletion or inhibition leads to an abrogation of NETosis in various contexts including bacterial infection, atherosclerosis, and the MRL/lpr SLE model (11–14). Here, PADI4 is linked to atherosclerosis.